| Competitor Name | Times Picked |
| SGLT2i Without DM | 705 |
| K Binders in CKD | 454 |
| Patient-Driven Choice for Dialysis | 328 |
| Biomarkers in Rejection | 282 |
| Percutaneous AVF Creation | 236 |
| Climate Change and CKD | 213 |
| End-of-Life care for Patients on Dialysis | 202 |
| Flu Vaccine | 196 |
| Consumable Waste in HD | 141 |
| Biopsy in Rejection | 114 |
| Policy-Driven Outcomes for Dialysis | 112 |
| K is Good in CKD | 97 |
| Marijuana OK | 94 |
| SGLT2i in Transplant | 93 |
| Exercise Prevents HyperK | 80 |
| Disposable Waste in HD | 78 |
| Climate Change and AKI | 78 |
| Pneumonia Vaccine | 61 |
| American Guidelines | 61 |
| Live Vaccines in Transplant | 57 |
| TG Feedback | 55 |
| Genetic Counseling for Cystic Diseases | 48 |
| EU Guidelines | 46 |
| Dialysis for Patients at End-of-Life | 38 |
| Non-TG Feedback | 37 |
| Women with X-linked Alport | 34 |
| Surgical AVFCreation | 32 |
| No Live Vaccines in Transplant | 24 |
| Autosomal Dominant Alport | 23 |
| Genetic Counseling for Stones | 23 |
| Marijuana Not OK | 18 |
| Exercise Causes HyperK | 12 |